Recent Finacing
Recent Raise
Zymeworks is a Vancouver-based biotherapeutics company developing Azymetric bispecific antibodies, AlbuCORE and ZymeCAD-enabled protein engineering, advancing preclinical ADC and bispecific oncology candidates toward IND and clinical trials.
